Clinical trial Recruiting at 1 site Interventional Ages 40 to 75

Dose-Response for Intra-Articular Ozone in Knee Osteoarthritis

Official title: Dose-Response Effect of Intra-Articular Ozone in Knee Osteoarthritis: A Randomized Controlled Single-Blind Clinical Study

Run by Kayseri City Hospital · NCT07678996 · Data updated 2026-11-12

This study tests whether different doses of ozone injections combined with a home exercise program can improve pain and function in people aged 40–75 with moderate knee osteoarthritis.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorKayseri City Hospital
Government
Locations1 site (Kayseri)
StatusRecruiting
StartedNovember 19, 2025
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedJuly 1, 2026
Trial IDNCT07678996 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–75 with Kellgren-Lawrence grade 2–3 knee osteoarthritis and chronic knee pain.

Probably not a fit

Individuals with recent knee infection, major knee trauma, inflammatory arthritis, or prior knee injections/physical therapy within the last 6 months may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized trial compares three ozone doses (10, 15, and 20 µg/mL) plus exercise to exercise alone in adults with Kellgren-Lawrence grade 2–3 knee OA. Participants receive three weekly intra-articular ozone injections alongside a structured home exercise program and are followed with clinical and functional assessments over 3 months. The goal is to determine the dose-dependent effects of ozone on pain and physical function and whether ozone adds benefit to exercise. The study is conducted at Kayseri City Hospital, with participants allocated by computerized randomization. All groups follow the same home exercise protocol, including ROM, strengthening, and flexibility exercises.

Why it matters

Potential benefit: If successful, patients might experience greater pain relief and improved knee function when ozone is added to exercise therapy.

How similar studies have gone: Prior studies of intra-articular ozone have shown varying results; this trial explores a dose-dependent approach with combined exercise, which is relatively novel in this specific OA setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 40-75 years diagnosed with knee osteoarthritis according to the American College of Rheumatology 2019 criteria
* Grade 2 or 3 knee osteoarthritis based on the Kellgren-Lawrence radiological classification system.
* Presence of chronic knee pain lasting for more than 6 months.
* Numerical Rating Scale score of 3 or higher during knee-loading activities

Exclusion Criteria:

* Presence or history of acute knee infection, major knee trauma, or inflammatory arthritis
* History of knee fracture or surgical intervention involving the affected knee joint within the last 6 months.
* History of intra-articular injections (e.g., corticosteroids, hyaluronic acid, PRP) into the affected knee joint within the last 6 months.
* History of physical therapy or rehabilitation in the knee region within the last 6 months
* Presence of osteomyelitis adjacent to the knee joint, bacteremia, or hemarthrosis.
* History of malignancy involving the lower extremity.
* Known hypersensitivity or allergy to medical ozone.
* Severe anemia, thrombocytopenia, active bleeding disorders, or ongoing anticoagulant therapy.
* Pregnancy or lactation
* Active infection
* Severe systemic diseases (e.g., advanced cardiopulmonary disease, uncontrolled diabetes mellitus).
* Hyperthyroidism or progressive neuromuscular disorders.
* Cognitive impairment or inability to cooperate with the assessment tools and study protocol.

Where it's running

  • Kayseri City Hospital
    Kayseri, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.